Forbion Growth Opportunities Fund I Cooperatief U.A.
SEC CIK 1911047 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ENGN | enGene Therapeutics Inc. | 10% | 2.46M | $3.01M | — | 1 | 2023-12-27 | 2023-12-27 |
Most active insiders at ENGN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Grossman William | Interim Chief Medical Off, Dir | $10.1K | — |
Forbion Growth Opportunities Fund I Cooperatief U.A. made no open-market trades at ENGN in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-10-18 | 2023-12-27+ | ENGN | enGene Therapeutics Inc. | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% | P - Purchase | $6.40 | +470.6K | 2.46M | +24% | +$3.01M |
Purchase Sale Sale after option exercise All abbreviations